SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 14, 2004
MACROPORE BIOSURGERY, INC.
(Exact name of registrant as specified in Charter)
Delaware |
| 000-32501 |
| 33-0827593 |
(State or Other Jurisdiction |
| (Commission File |
| (IRS Employer |
|
|
|
|
|
6740 Top Gun Street, San Diego, California |
| 92121 | ||
(Address of Principal Executive Offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: (858) 458-0900
Item 5: Other Events and Regulation FD Disclosure.
MacroPore Biosurgery, Inc. reported the sale of its bioresorbable film implant business to MAST Biosurgery, AG in a press release dated May 14, 2004, attached hereto as Exhibit 99.1.
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit 99.1 | Press release issued by MacroPore Biosurgery, Inc. on May 14, 2004, announcing the sale of its bioresorbable film implant business to MAST Biosurgery, AG in a press release dated May 14, 2004. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| MACROPORE BIOSURGERY, INC. | |
|
|
| |
|
|
| |
Dated: May 14, 2004 | By: | /s/ Christopher J. Calhoun |
|
|
| Christopher J. Calhoun | |
|
| President and Chief Executive Officer |
3
EXHIBIT INDEX
Exhibit |
| Description of Document |
|
|
|
99.1 |
| Press release issued by MacroPore Biosurgery, Inc. on May 14, 2004, announcing the sale of its bioresorbable film implant business to MAST Biosurgery, AG in a press release dated May 14, 2004 |
4